EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.806
https://www.valueinhealthjournal.com/article/S1098-3015(22)03010-8/fulltext
Title :
EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03010-8&doi=10.1016/j.jval.2022.09.806
First page :
Section Title :
Open access? :
No
Section Order :
10346